These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11714444)

  • 21. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
    Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
    Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic loss on 17p13 (TP53) and allelic loss on 3p21 in early squamous cell carcinoma of the lung.
    Endo C; Sato M; Fujimura S; Sakurada A; Aikawa H; Takahashi S; Usuda K; Saito Y; Sagawa M
    Surg Today; 2000; 30(8):695-9. PubMed ID: 10955731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic instability as a predictor of survival in Egyptian breast cancer patients.
    Zekri AR; Bahnassi AA; Bove B; Huang Y; Russo IH; Rogatko A; Shaarawy S; Shawki OA; Hamza MR; Omer S; Khaled HM; Russo J
    Int J Oncol; 1999 Oct; 15(4):757-67. PubMed ID: 10493959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsatellite alterations in patients with thoracic sarcoma.
    Iyoda A; Hiroshima K; Toyozaki T; Baba M; Fujisawa T; Yusa T; Ohwada H
    Oncol Rep; 2001; 8(4):917-21. PubMed ID: 11410810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Heterozygosity (LOH) at 17p13 and 22q13 are Shared by Breast and Thyroid Carcinomas for Metastasis.
    Lin X; Finkelstein SD; Silverman JF
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):e16-e19. PubMed ID: 30688674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype.
    Garcia JM; Silva JM; Dominguez G; Gonzalez R; Navarro A; Carretero L; Provencio M; España P; Bonilla F
    Breast Cancer Res Treat; 1999 Oct; 57(3):237-43. PubMed ID: 10617300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.
    Nowacka-Zawisza M; Forma E; Walczak M; Różański W; Bryś M; Krajewska WM
    Med Oncol; 2015 Nov; 32(11):246. PubMed ID: 26433958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular changes in primary breast tumors and the Nottingham Histologic Score.
    Ellsworth RE; Hooke JA; Love B; Ellsworth DL; Shriver CD
    Pathol Oncol Res; 2009 Dec; 15(4):541-7. PubMed ID: 19194786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
    Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer.
    Försti A; Louhelainen J; Söderberg M; Wijkström H; Hemminki K
    Eur J Cancer; 2001 Jul; 37(11):1372-80. PubMed ID: 11435067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
    Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
    Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
    Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
    Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas.
    Grati FR; Sirchia SM; Garagiola I; Sironi E; Galioto S; Rossella F; Serafini P; Dulcetti F; Bozzetti A; Brusati R; Simoni G
    Cancer Genet Cytogenet; 2000 Apr; 118(1):57-61. PubMed ID: 10731592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.
    Jung HL; Wang KC; Kim SK; Sung KW; Koo HH; Shin HY; Ahn HS; Shin HJ; Cho BK
    J Neurooncol; 2004; 67(1-2):41-6. PubMed ID: 15072446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
    Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.